Shinsuke Shiotsu Selected Research

Drug Therapy (Chemotherapy)

1/2024	Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.
1/2024	Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.
11/2023	Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status.
10/2023	First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.
6/2023	Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations: a multicenter retrospective study.
4/2023	Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive-Stage SCLC Who Received Programmed Cell Death-Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study.
1/2023	Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.
1/2023	Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation: A multicenter retrospective study.
1/2023	Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy.
10/2022	Efficacy and Safety of Paclitaxel/nab-paclitaxel Chemotherapy for Patients With Relapsed Small Cell Lung Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinsuke Shiotsu Research Topics

Disease

31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 10/2018
26	Neoplasms (Cancer) 03/2024 - 01/2010
11	Lung Neoplasms (Lung Cancer) 03/2024 - 01/2019
3	Disease Progression 01/2024 - 10/2018
3	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2018
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 09/2022
3	Pleural Effusion (Pleural Effusions) 01/2019 - 01/2010
2	Respiratory Insufficiency (Respiratory Failure) 03/2024 - 11/2020
2	Adenocarcinoma of Lung 04/2023 - 02/2023
2	Dyspnea (Shortness of Breath) 05/2022 - 01/2012
2	Fever (Fevers) 05/2022 - 12/2021
2	COVID-19 12/2021 - 11/2020
2	Hemorrhage 01/2021 - 10/2010
2	Purpura 01/2021 - 01/2010
2	Pneumonia (Pneumonitis) 11/2020 - 10/2010
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2024
1	Cytokine Release Syndrome 03/2024
1	Shock 03/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2024
1	Inflammation (Inflammations) 09/2023
1	Cachexia 09/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Pericardial Effusion 12/2022
1	Rhinosinusitis 05/2022
1	Churg-Strauss Syndrome (Allergic Angiitis) 05/2022
1	Bronchiectasis 05/2022
1	Atopic Dermatitis (Atopic Eczema) 05/2022
1	Asthma (Bronchial Asthma) 05/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 12/2021
1	Infections 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Pancytopenia 01/2021
1	Epistaxis (Nosebleed) 01/2021
1	Vascular Diseases (Vascular Disease) 11/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2020

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
11	Tyrosine Kinase InhibitorsIBA 01/2023 - 10/2018
10	ErbB Receptors (EGF Receptor)IBA 06/2023 - 10/2018
8	osimertinibIBA 06/2023 - 01/2019
6	B7-H1 AntigenIBA 10/2023 - 08/2019
4	RamucirumabIBA 03/2024 - 08/2019
4	Docetaxel (Taxotere)FDA Link 03/2024 - 08/2019
4	PlatinumIBA 01/2024 - 01/2023
4	pembrolizumabIBA 11/2023 - 01/2021
3	AntibodiesIBA 03/2024 - 11/2020
3	LigandsIBA 11/2023 - 01/2022
3	Anaplastic Lymphoma KinaseIBA 01/2023 - 11/2021
2	NivolumabIBA 03/2024 - 07/2018
2	Etoposide (VP 16)FDA LinkGeneric 04/2023 - 01/2023
2	AfatinibIBA 01/2022 - 10/2018
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 12/2021 - 11/2020
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 12/2018
2	Keratin-19 (Keratin 19)IBA 06/2019 - 07/2018
1	IpilimumabIBA 03/2024
1	SteroidsIBA 03/2024
1	serum P-component (CIt)IBA 10/2023
1	C-Reactive ProteinIBA 09/2023
1	durvalumabIBA 09/2023
1	Epidermal Growth Factor (EGF)IBA 06/2023
1	RNA (Ribonucleic Acid)IBA 02/2023
1	Proteins (Proteins, Gene)FDA Link 02/2023
1	lorlatinibIBA 01/2023
1	Proton Pump InhibitorsIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 12/2022
1	130-nm albumin-bound paclitaxelIBA 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2022
1	Topoisomerase II InhibitorsIBA 09/2022
1	EnzymesIBA 09/2022
1	amrubicinIBA 09/2022
1	DNA (Deoxyribonucleic Acid)IBA 09/2022
1	dupilumabIBA 05/2022
1	Antineoplastic Agents (Antineoplastics)IBA 03/2022
1	VimentinIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	ciclesonide FDA Link 12/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2021
1	Dacarbazine (DIC)FDA LinkGeneric 12/2021
1	Brentuximab VedotinIBA 12/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 12/2021
1	favipiravirIBA 12/2021
1	alectinibIBA 11/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	AlbuminsIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Danazol (Azol)FDA LinkGeneric 01/2021
1	CollagenIBA 11/2020

Therapy/Procedure

17	Therapeutics 03/2024 - 07/2018
15	Drug Therapy (Chemotherapy) 01/2024 - 01/2019
6	Immunotherapy 10/2023 - 08/2019
1	Chemoradiotherapy 09/2023
1	Traction 05/2022